Psychedelic Therapy Washington DC, Maryland & Virginia: 2026 Guide
Last Updated: May 2026 If you’re looking for psychedelic therapy in Washington DC, Maryland, or Virginia (DMV), your clearest option right now is ketamine, which is...
Executive Burnout Psychedelic Therapy: What the Research Shows
Executive burnout psychedelic therapy is moving from the research margins into serious clinical conversation. A growing body of peer-reviewed evidence suggests that psilocybin-assisted therapy can reduce...
Psilocybin Alcohol Use Disorder: What Hopkins and NYU Research Found
Research on psilocybin alcohol use disorder treatment, including a landmark 2022 randomized controlled trial published in JAMA Psychiatry, has shown meaningful reductions in heavy drinking days...
Psychedelics and Creativity: What Executives Need to Know
Interest in psychedelics and creativity among executives has moved well beyond Silicon Valley. Neuroscientific research points to measurable changes in divergent thinking, cognitive flexibility, and problem-solving...
Psychedelic Therapy Privacy: What Executives Need to Know
Psychedelic therapy privacy is one of the most legitimate concerns executives and public figures raise before pursuing treatment. HIPAA protections apply to licensed clinical providers, and...
Set and Setting in 2026: A Psychedelic Preparation Guide for High-Performers
Set and setting psychedelics research refers to the two core non-pharmacological factors that shape a psilocybin experience: your internal state (set) and the physical and relational...
What executives are actually using psychedelic therapy for (and what the data shows)
Psychedelic therapy for executives is moving beyond reputation and into clinical evidence. A growing number of C-suite leaders are using professionally supported psilocybin and ketamine experiences...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.